Physician profile
David Sherman
NPI 1427375229
$1,528.93
in general payments reported to CMS, 2019-2025
9 companies · $65.39 in 2025
The $65.39 reported for 2025 was less than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $101 · 2021: $400 · 2022: $68.56 · 2023: $539 · 2024: $226 · 2025: $65.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $715 · Consulting Fee: $75.00 · Education: $40.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $714.62 |
| Consulting Fee | $75.00 |
| Education | $40.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $526.75 | 2019-2025 | Itero Element 5d Plus Lite, Invisalign |
| American Orthodontics Corporation | $406.56 | 2019-2021 | |
| Lightforce Orthodontics, INC. | $164.22 | 2023 | |
| Straumann USA LLC | $125.58 | 2023 | |
| Dentsply Sirona INC | $112.77 | 2024 | Waveone Gold Conform Fit |
| 3m Company | $81.48 | 2021-2022 | |
| Nobel Biocare USA | $37.59 | 2023 | Nobelactive |
| Ormco Corporation | $37.59 | 2023 | Spark |
| Envista Holdings Corporation | $36.39 | 2024-2025 | Spark, Ortho Solo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sherman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.